Methotrexate loaded lipid nanoparticles for topical management of skin-related diseases: Design, characterization and skin permeation potential
- 1 October 2016
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 512 (1) , 14-21
Abstract
No abstract availableKeywords
Funding Information
- European Union
- national funds
This publication has 30 references indexed in Scilit:
- Structure and Function of the Stratum Corneum Extracellular MatrixJournal of Investigative Dermatology, 2012
- Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicityJournal of the European Academy of Dermatology and Venereology, 2011
- Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasisInternational Journal of Pharmaceutics, 2010
- Methotrexate: the gold standard without standardisationAnnals of the Rheumatic Diseases, 2009
- Effects of extracellular calcium on the growth‐differentiation switch in immortalized keratinocyte HaCaT cells compared with normal human keratinocytesExperimental Dermatology, 2009
- Development of Nitrendipine Controlled Release Formulations Based on SLN and NLC for Topical Delivery: In Vitro and Ex Vivo CharacterizationDrug Development and Industrial Pharmacy, 2008
- Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and chargeInternational Journal of Pharmaceutics, 2004
- S100C/A11 is a key mediator of Ca2+-induced growth inhibition of human epidermal keratinocytesJournal of Cell Biology, 2003
- Nanosuspensions as particulate drug formulations in therapyAdvanced Drug Delivery Reviews, 2001
- Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEuropean Journal of Pharmaceutics and Biopharmaceutics, 2000